Hepatitis SA flourish
HepSA Community News

Site navigation

  • Issues
  • About
  • Contributions
  • Contact

Our sites

  • Hepatitis SA
  • HepSA Community News
  • Hepatitis SA Library
  • Facebook
  • Bluesky
  • Twitter
  • Issuu
  • Youtube
  • Copyright & Disclaimer
  • Complaints Policy
  • Feedback
  • Subscribe for Updates

Copyright © 2024–2026 Hepatitis SA

HepSA Community News

Issues
  • Community
  • Policies & Research
  • Resources
  • Living with Hepatitis
  • All Articles

Featured article

The over‑50s are most likely to overdose. Here’s how older people use drugs

Latest figures from the Pennington Institute show that older Australians make up the highest proportion of unintentional overdose deaths.

Community

Australia’s Deadliest Year of Drug Overdoses

New data from the Penington Institute has revealed that 2,272 Australians died of drug-induced deaths in 2023, with the rate of unintentional overdoses increasing to nearly 80 per cent. On average,…

4474 Lives Saved, But Targets Will Not Be Met

Powerful new data from the 2024 annual report for Measuring the progress towards the targets of the National Hepatitis B Strategy (launched by The Peter Doherty Institute at the end…

More from Community

Living with Hepatitis

Results on New Hep B Drug: How good is it?

Pharmaceutical giant, GSK, who seem to be leading the field in developing a hepatitis B functional cure, has finally presented the results on their new drug, bepirovirsen. The 254 million…

Hep B Functional Cure – a plain language explainer

There has been a lot of talk about a functional cure for hepatitis B. What exactly does that mean? And how does that affect someone who’s living with chronic hepatitis…

More from Living with Hepatitis

Policies & Research

In Our Library: May 2026 Highlights

The national hepatitis strategies, Viral Hepatitis Mapping Project reports, and more… Click on the images to access, or view all resources added in the last month Sixth national hepatitis C strategy 2025…

China Deal on Potential Hep B Cure

Pharmaceutical giant GSK has announced that it has entered into an exclusive collaboration with the Hong Kong-based pharma company Sino Biopharmaceutical to sell in mainland China, a chronic ​hepatitis B…

More from Policies & Research

Resources

Lung Cancer Screening Saves Lives

Hepatitis SA’s harm reduction peer services is encouraging clients and community members to consider lung cancer screening with the Australian government’s free lung screen program. Screening is a way of…

Is it Safe to Ask AI for Health Advice?

People are increasingly relying on “AI” sources for health information, but is it safe to do so? Worldwide, one in four queries to ChatGPT are health related, while almost one…

More from Resources

Enjoy our articles? Subscribe to be notified whenever we publish new stories. You can unsubscribe any time.

Subscribe for Updates

Issue 109

May 2026

Read this issue
Browse other issues

Hepatitis SA

Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians living with and affected by hepatitis B and hepatitis C.

Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.

Our sites

  • Hepatitis SA
  • HepSA Community News
  • Hepatitis SA Library
  • Facebook
  • Bluesky
  • Twitter
  • Issuu
  • Youtube

Contact

Kaurna Country
3 Hackney Road
Hackney, SA, 5069

PO Box 782
Kent Town, SA, 5071

(08) 8362 8443

Hepatitis SA Helpline
1800 437 222

  • Copyright & Disclaimer
  • Complaints Policy
  • Feedback
  • Subscribe for Updates

Copyright © 2024–2026 Hepatitis SA